News tagged with respiratory diseases

AstraZeneca in $560 m deal for respiratory firm

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

Jun 10, 2013
popularity not rated yet | comments 0

'Black lung is back' researcher says

The dangers of coal mining enter the spotlight periodically when disasters strike, but one West Virginia University researcher argues that coal mine dust exposure, which has caused an increase in the prevalence and severity ...

May 17, 2013
popularity 5 / 5 (1) | comments 0